COLL | COLLEGIUM PHARMACEUTICAL INC

CUSIP: 19459J104

1 Funds Holding

203K Total Shares

$9M Total Value

$1.5B

Market Cap

28.3

P/E Ratio

5.8

Forward P/E

$1.63

EPS (TTM)

—

Dividend Yield

$286M

Cash

$859M

Total Debt

32M

Shares Out

$23.23

$50.79

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Third Avenue Management\|Matthew Fine	203.4K	$9M	1.71%	$30.13	+56.34%

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2024-Q4
Third Avenue Management	BUY	+11.4%	203.4K	$6M	$31.33
2024-Q3
Third Avenue Management	BUY	+0.2%	182.7K	$7M	$36.08
2024-Q2
Third Avenue Management	BUY	+68.6%	182.3K	$6M	$34.25
2024-Q1
Third Avenue Management	BUY	+30.1%	108.1K	$4M	$33.49
2023-Q4
Third Avenue Management	BUY	NEW	83.1K	$3M	$25.11

6 Months Insider Sentiment

100%

Buy $0 Sell $4.6M

0 Buys

7 Sells

-4.6M Net

0 Grants

Largest

$1.6M Fallon

$1.0M Tupper

$672K Smith

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Dec 08, 2025	Scott Dreyer	EVP & Chief Commercial Officer	SELL	11.1K	$47.89	$533K
Dec 08, 2025	Scott Dreyer	EVP & Chief Commercial Officer	EXERCISE	17.6K	$15.90	$280K
Dec 08, 2025	Scott Dreyer	EVP & Chief Commercial Officer	SELL	6.5K	$48.66	$315K
Dec 05, 2025	Rita J. Balice-Gordon	Director	SELL	3.6K	$47.03	$172K
Nov 12, 2025	John A. Fallon	Director	EXERCISE	19.9K	$9.33	$185K
Nov 12, 2025	John A. Fallon	Director	EXERCISE	15.0K	$16.49	$247K
Nov 12, 2025	John A. Fallon	Director	SELL	34.9K	$47.21	$1.6M
Nov 06, 2025	Colleen Tupper	EVP & Chief Financial Officer	SELL	4.9K	$41.28	$201K
Nov 06, 2025	Colleen Tupper	EVP & Chief Financial Officer	SELL	25.1K	$40.38	$1.0M
Aug 29, 2025	Thomas B Smith	EVP and Chief Medical Officer	SELL	17.5K	$38.42	$672K

Institutional Ownership of COLLEGIUM PHARMACEUTICAL INC